- Home
- OIA vs SOPH Comparison
OIA vs SOPH Comparison
Compare OIA & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OIA | SOPH |
|---|---|---|
| Founded | 1988 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 290.8M | 330.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | OIA | SOPH |
|---|---|---|
| Price | $6.04 | $4.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 97.9K | 73.7K |
| Earning Date | 01-01-0001 | 11-04-2025 |
| Dividend Yield | ★ 4.88% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $73,297,000.00 |
| Revenue This Year | N/A | $18.32 |
| Revenue Next Year | N/A | $15.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.66 |
| 52 Week Low | $4.93 | $2.58 |
| 52 Week High | $6.72 | $5.30 |
Technical Indicators
Market Signals| Indicator | OIA | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 49.76 | 52.71 |
| Support Level | $5.93 | $4.56 |
| Resistance Level | $6.13 | $4.84 |
| Average True Range (ATR) | 0.08 | 0.21 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 41.93 | 58.04 |
Price Performance
Historical ComparisonAbout OIA Invesco Municipal Income Opportunities Trust
Invesco Muni Income Opps Trust operates as a diversified closed-end management investment company. Its investment objective is to provide a high level of current income which is exempt from federal income tax.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.